×
S&P 500   3,839.75 (+0.22%)
DOW   30,992.99 (+0.08%)
QQQ   290.18 (+1.12%)
AAPL   143.82 (+1.60%)
MSFT   267.33 (+1.70%)
META   170.58 (+1.42%)
GOOGL   2,304.29 (+1.72%)
AMZN   114.86 (+1.20%)
TSLA   697.69 (-0.22%)
NVDA   152.33 (+1.80%)
NIO   20.84 (-6.04%)
BABA   119.84 (-0.24%)
AMD   75.91 (+0.94%)
MU   57.70 (+1.71%)
CGC   2.68 (-1.11%)
T   21.18 (+0.05%)
GE   61.83 (-0.32%)
F   11.16 (-0.36%)
DIS   96.68 (-0.51%)
AMC   12.60 (-1.41%)
PFE   52.90 (+2.44%)
PYPL   73.73 (-0.90%)
NFLX   185.18 (-0.38%)
S&P 500   3,839.75 (+0.22%)
DOW   30,992.99 (+0.08%)
QQQ   290.18 (+1.12%)
AAPL   143.82 (+1.60%)
MSFT   267.33 (+1.70%)
META   170.58 (+1.42%)
GOOGL   2,304.29 (+1.72%)
AMZN   114.86 (+1.20%)
TSLA   697.69 (-0.22%)
NVDA   152.33 (+1.80%)
NIO   20.84 (-6.04%)
BABA   119.84 (-0.24%)
AMD   75.91 (+0.94%)
MU   57.70 (+1.71%)
CGC   2.68 (-1.11%)
T   21.18 (+0.05%)
GE   61.83 (-0.32%)
F   11.16 (-0.36%)
DIS   96.68 (-0.51%)
AMC   12.60 (-1.41%)
PFE   52.90 (+2.44%)
PYPL   73.73 (-0.90%)
NFLX   185.18 (-0.38%)
S&P 500   3,839.75 (+0.22%)
DOW   30,992.99 (+0.08%)
QQQ   290.18 (+1.12%)
AAPL   143.82 (+1.60%)
MSFT   267.33 (+1.70%)
META   170.58 (+1.42%)
GOOGL   2,304.29 (+1.72%)
AMZN   114.86 (+1.20%)
TSLA   697.69 (-0.22%)
NVDA   152.33 (+1.80%)
NIO   20.84 (-6.04%)
BABA   119.84 (-0.24%)
AMD   75.91 (+0.94%)
MU   57.70 (+1.71%)
CGC   2.68 (-1.11%)
T   21.18 (+0.05%)
GE   61.83 (-0.32%)
F   11.16 (-0.36%)
DIS   96.68 (-0.51%)
AMC   12.60 (-1.41%)
PFE   52.90 (+2.44%)
PYPL   73.73 (-0.90%)
NFLX   185.18 (-0.38%)
S&P 500   3,839.75 (+0.22%)
DOW   30,992.99 (+0.08%)
QQQ   290.18 (+1.12%)
AAPL   143.82 (+1.60%)
MSFT   267.33 (+1.70%)
META   170.58 (+1.42%)
GOOGL   2,304.29 (+1.72%)
AMZN   114.86 (+1.20%)
TSLA   697.69 (-0.22%)
NVDA   152.33 (+1.80%)
NIO   20.84 (-6.04%)
BABA   119.84 (-0.24%)
AMD   75.91 (+0.94%)
MU   57.70 (+1.71%)
CGC   2.68 (-1.11%)
T   21.18 (+0.05%)
GE   61.83 (-0.32%)
F   11.16 (-0.36%)
DIS   96.68 (-0.51%)
AMC   12.60 (-1.41%)
PFE   52.90 (+2.44%)
PYPL   73.73 (-0.90%)
NFLX   185.18 (-0.38%)
OTCMKTS:USAQ

QHSLab Stock Forecast, Price & News

$0.34
0.00 (0.00%)
(As of 07/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.34
$0.34
50-Day Range
$0.33
$0.54
52-Week Range
$0.23
$1.00
Volume
N/A
Average Volume
339 shs
Market Capitalization
$2.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

QHSLab MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.01% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.75mentions of QHSLab in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.04) to $0.14 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.43 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive USAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QHSLab and its competitors with MarketBeat's FREE daily newsletter.

QHSLab logo

About QHSLab (OTCMKTS:USAQ) Stock

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

USAQ Stock News Headlines

USA Equities Corp - Class A (USAQ)
USA Equities Corp.A reports Q1 results
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:USAQ
Fax
N/A
Employees
3
Year Founded
N/A

Company Calendar

Last Earnings
11/16/2021
Today
7/06/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$-770,000.00
Pretax Margin
-59.59%

Debt

Sales & Book Value

Annual Sales
$1.41 million
Book Value
$0.09 per share

Miscellaneous

Free Float
2,260,000
Market Cap
$2.98 million
Optionable
Not Optionable
Beta
-1.49














QHSLab Frequently Asked Questions

Should I buy or sell QHSLab stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for QHSLab in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" QHSLab stock.
View analyst ratings for QHSLab
or view top-rated stocks.

How has QHSLab's stock performed in 2022?

QHSLab's stock was trading at $0.73 at the beginning of 2022. Since then, USAQ stock has decreased by 53.4% and is now trading at $0.34.
View the best growth stocks for 2022 here
.

Are investors shorting QHSLab?

QHSLab saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 1,100 shares, a decline of 65.6% from the May 15th total of 3,200 shares. Based on an average daily trading volume, of 5,700 shares, the short-interest ratio is currently 0.2 days.
View QHSLab's Short Interest
.

How were QHSLab's earnings last quarter?

QHSLab, Inc. (OTCMKTS:USAQ) issued its quarterly earnings results on Tuesday, November, 16th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01. The firm earned $0.32 million during the quarter. QHSLab had a negative trailing twelve-month return on equity of 0.60% and a negative net margin of 59.57%.
View QHSLab's earnings history
.

Who are QHSLab's key executives?

QHSLab's management team includes the following people:
  • Mr. Troy James Grogan, CEO, CFO, Pres & Chairman (Age 45)
  • Ms. Cyndi Cole, Financial Controller
  • Olivia Giamanco, Marketing Director

What is QHSLab's stock symbol?

QHSLab trades on the OTCMKTS under the ticker symbol "USAQ."

How do I buy shares of QHSLab?

Shares of USAQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is QHSLab's stock price today?

One share of USAQ stock can currently be purchased for approximately $0.34.

How much money does QHSLab make?

QHSLab (OTCMKTS:USAQ) has a market capitalization of $2.98 million and generates $1.41 million in revenue each year.

How many employees does QHSLab have?

QHSLab employs 3 workers across the globe.

How can I contact QHSLab?

QHSLab's mailing address is 901 NORTHPOINT PARKWAY SUITE 302, WEST PALM BEACH FL, 33407. The official website for QHSLab is www.usaqcorp.com. The company can be reached via phone at (929) 379-6503 or via email at admin@medicalpracticeincome.com.

This page (OTCMKTS:USAQ) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.